Abstract
Since the late 1990s, the term “Personalized Medicine” has been coined to enable collaborations between different stakeholders in and outside research units. As a concept, it constitutes an imaginary framework of expectations and claims for a better, patient-centered and efficient health care system. Rather than deciding whether such trends represent “hype” or “hope”, scholars from the social studies of technology and science emphasize that the expectations revolving around new technology are not only accessory parts of scientific inventions or innovation networks. Instead, they regard them essential in shaping these technologies. The aim of the following chapters 4 and 5 is twofold: (4) analyzing the semantic and socio-cultural contexts in which new technologies could come into being or be implemented on a larger scale (5) analyzing the continuing significance of epistemological key categories (e.g. the focus on the biological individuality) in the field of medical research and practice, and their influence on past visions of medical future.
Chapter 4 analyzes writings about “Personalized Medicine” addressed to a scientific and a popular public. They represent different promoting strategies while sharing normative assumptions that are rarely articulated: “Personalized Medicine” is made to appear to be part and parcel of a venerable tradition of past medical advances, an “invented tradition” that seems to herald a brighter and more democratic future for (Western) societies. Debates about the implications of new trends need to render the normativity of such claims explicit to allow for more informed judgments, rational critique and a more careful choice of research priorities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adam B (1998) Timescapes of modernity. The environment and invisible hazards. Routledge, London
Angrist M (2010) Here is a human being: at the dawn of personal genomics. HarperCollins, New York
Borup M, Brown N, Konrad K et al (2006) The sociology of expectation in science and technology. Technol Anal Strateg 18(3/4):285–298. doi:10.1080/09537320600777002
Brown N, Rappert B, Webster A (eds) (2000) Contested futures: a sociology of prospective techno-science. Ashgate, Aldershot
Brown N, Michael M (2003) A sociology of expectations: retrospecting prospects and prospecting retrospects. Technol Anal Strateg 15(1):3–18
Bynum WF (1994) Science and the practice of medicine in the nineteenth century. Cambridge University Press, Cambridge
Cantor C (1999) Pharmacogenetics becomes pharmacogenomics: wake up and get ready. Mol Diagn 4(4):287–288
Collins FS (2010a) The language of life: dna and the revolution in personalized medicine. HarperCollins, New York
Collins FS (2010b) Has the revolution arrived? Nature 464:674–675. doi:10.1038/464674a
Dabrock P, Braun M, Ried J (eds) (2012) Individualized medicine between hype and hope: exploring ethical and societal challenges for healthcare. LIT Verlag, Wien
Davies K (2010) The $ 1,000 Genome: the revolution in DNA sequencing and the new era of personalized medicine. Simon & Schuster, New York
Frank L (2009) Mindfield: how brain science is changing our world. Oneworld Publications, London
Frank L (2011) My beautiful genome: exposing our genetic future, one quirk at a time. Oneworld Publications, London
Goetz T (2010) The decision tree: taking control of your health in the era of personalized medicine. Rodale, New York
Gollust SE, Chandros S, Wilfond BS (2002) Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 288:1762–1767
Gordon D (1988) Clinical science and clinical expertise: changing boundaries between art and science in medicine. In: Lock M, Gordon D (eds) Biomedicine examined. Kluwer, London, pp 257–298
Gottlieb S (2012) Digital doctoring. Wall Street Journal. http://online.wsj.com/news/articles/SB10001424052970204740904577193191077117530. Accessed 8 July 2014
Guice J (1999) Designing the future: the culture of new trends in science and technology. Res Policy 28(1):81–98
Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363:301–304
Hedgecoe A, Martin P (2003) The drugs don’t work: expectations and the shaping of pharmacogenetics. Soc Stud Sci 33(3):327–364
Hedgecoe A (2004) The politics of personalised medicine—Pharmacogenetics in the clinic. Cambridge University Press, Cambridge
Hobsbawm E, Ranger T (1992) The invention of tradition. Cambridge University Press, Cambridge
Horwitz RI, Cullen MR, Abell J et al (2013) (De)Personalized medicine. Science 339:1155–1156
Howard H, Borry P (2012) To ban or not to ban? Clinical geneticists’ views on the regulation of direct-to-consumer genetic testing. EMBO reports 13(9):791–794
Jain KK (2009) Textbook on personalized medicine. Springer, Dordrecht
Jørgensen JT (2009) New era of personalized medicine: a 10-Year anniversary. Oncologist 14(5):557–558. doi:10.1634/theoncologist.2009-0047
Juengst ET, Settersten RA, Fishman JR et al (2012a) After the revolution? Ethical and social challenges in “personalized genomic medicine”. Per Med 9:429–439
Juengst ET, Flatt MA, Settersten RA (2012b) Personalized genomic medicine and the rhetoric of empowerment. Hastings Cent Rep 42(5):34–40. doi:10.1002/hast.65
Kennedy D (2007) Breakthrough of the year. Science 318(5858):1833. doi:10.1126/science.1154158
Langreth R, Waldholz M (1999) New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist 4(5):426–427. doi:10.1634/theoncologist.2009-0047
Lengwiler M, Madarász J (eds) (2010) Das präventive Selbst. Eine Kulturge-schichte moderner Gesundheitspolitik. transcript, Bielefeld
Marshall A (1997a) Laying the foundations for personalized medicines. Nat Biotechnol 15:954–957. doi:10.1038/nbt1097-954
Marshall A (1997b) Getting the right drug into the right patient. Nat Biotechnol 15(12):1249–1252
Martin P (1999) Genes as drugs: the social shaping of gene therapy and the reconstruction of genetic disease. Sociol Health Illness 21(5):517–538
Martin P, Brown N, Kraft A (2008) From bedside to bench? Communities of promise, translational research and the making of blood stem cells. Sci Cult 17(1):29–41. doi:10.1080/09505430701872921
McGowan ML, Settersten RA, Juengst ET et al (2014) Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine. Urol Oncol 32(2):187–192. doi:10.1016/j.urolonc.2013.10.009
Myers G (1990) Writing biology: texts in the social construction of scientific knowledge. University of Wisconsin Press, Madison
Paul NW, Banerjee M, Michl S (2014) Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing. J Comm Genet 5:81–87
Prainsack B (2005) Personalized medicine in times of “global genes”:making sense of the “hype”. Per Med 2(2):173–174
Prainsack B (2014) The powers of participatory medicine. PLoS Biol 12(4):e1001837. doi:10.1371/journal.pbio.1001837
Pray L (2008) Personalized medicine: hope or hype? Nat Educ 1(1):72
Roses AD (2000) Pharmacogenetics and the practice of medicine. Nature 405:857–865. doi:10.1038/35015728
Schlich T (2007) The art and science of surgery: innovation and concepts of medical practice in operative fracture care, 1960s-1970s. Sci Technol Hum Val 32(1):65–87
Schumpeter JA (1942) Capitalism, socialism and democracy. Harper, New York
Selin C (2006) Time matters: temporal harmony and dissonance in nanotechnology networks. Time Soc 15(1):121–139. doi:10.1177/0961463X06061786
Stock G, Sydow S (2013) Personalisierte Medizin. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz 56(11):1495–1501
Topol E (2012) The creative destruction of medicine: how the digital revolution will create better health care. Basic Books, New York
Tutton R (2012) Personalizing medicine: futures present and past. Soc Sci Med 75(10):1721–1728
Vanfleteren LE, Kocks JW, Stone IS et al (2014) Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax 69(1):72–79. doi:10.1136/thoraxjnl-2013-203602
Van Lente H (1993) Promising Technology: the dynamics of expectations in technological development. PhD Thesis, Department of Philosophy of Science and Technology University of Twente, Enschede
Van Lente H, Rip A (1998) The rise of membrane technology: from rhetorics to social reality. Soc Studies Sci 28(2):221–254. doi:10.1177/030631298028002002
Wainwright SP, Michael M, Williams C (2008) Shifting paradigms? Reflections on regenerative medicine, embryonic stem cells and pharmaceutical. Sociol Health Ill 30(6):959–974. doi:10.1111/j.1467-9566.2008.01118.x
Yurkiewicz S (2010) The prospects for personalized medicine. Hastings Cent Rep 40(5):14–16
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Michl, S. (2015). Inventing Traditions, Raising Expectations. Recent Debates on “Personalized Medicine”. In: Fischer, T., Langanke, M., Marschall, P., Michl, S. (eds) Individualized Medicine. Advances in Predictive, Preventive and Personalised Medicine, vol 7. Springer, Cham. https://doi.org/10.1007/978-3-319-11719-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-11719-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11718-8
Online ISBN: 978-3-319-11719-5
eBook Packages: MedicineMedicine (R0)